Literature DB >> 9881387

Platelets and cardiopulmonary bypass.

J A Hyde1, J A Chinn, T R Graham.   

Abstract

Exposure of blood to an extracorporeal circulation, such as CPB, causes a variety of physiological responses. Haematological derangements are just one of many potential dangers to the patient who undergoes CPB. The paradox of CPB-related problems with the haematological system is that there are some factors tipping the balance towards a bleeding tendency, and others that favour a prothrombotic state. Both of these issues must be dealt with independently to create the safest environment for surgery. It has been demonstrated that platelets play a key role in both haemostatic dysfunction and thrombotic complications of CPB. Much has been achieved, both clinically and in the laboratory, in the understanding of the precise role platelets play in these events, but the exact mechanisms involved have yet to be completely identified. As research progresses, our understanding will increase, but until then clinical practice must be dictated by the current evidence available.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881387     DOI: 10.1177/026765919801300603

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  5 in total

Review 1.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

Review 2.  Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-01-23       Impact factor: 2.300

3.  Anticoagulant therapy during cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-10-19       Impact factor: 2.300

4.  Combined blockade of ADP receptors and PI3-kinase p110β fully prevents platelet and leukocyte activation during hypothermic extracorporeal circulation.

Authors:  Stefanie Krajewski; Julia Kurz; Tobias Geisler; Karlheinz Peter; Hans Peter Wendel; Andreas Straub
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

5.  Clopidogrel use After Myocardial Revascularization: Prevalence, Predictors, and One-Year Survival Rate.

Authors:  Paulo Roberto L Prates; Judson B Williams; Rajendra H Mehta; Susanna R Stevens; Laine Thomas; Peter K Smith; L Kristin Newby; Renato A K Kalil; John H Alexander; Renato D Lopes
Journal:  Braz J Cardiovasc Surg       Date:  2016-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.